Tag: vaccines

WHO Doubles Down On Global Vaccine Agenda 2030: More Shots, More “Misinformation” Crackdowns, And Zero Accountability For Harms

In a message released this week, Dr. Kate O’Brien, Director of the World Health Organization’s Department of Immunization, Vaccines and Biologicals, delivered a clear warning to the world: the globalist vaccine agenda is not slowing down — it’s accelerating.

Marking the halfway point of the Immunization Agenda 2030 (IA2030) at the 79th World Health Assembly, O’Brien and global health partners recommitted to “reaching everyone, everywhere with life-saving vaccines.” They called immunization the “most powerful, cost-effective and equitable health intervention” and positioned strong vaccine programs as the cornerstone of “global health security” and emergency preparedness.

O’Brien openly admits routine immunization coverage is slipping in many countries, outbreaks of “vaccine-preventable diseases” are spreading, and inequities are worsening. But instead of pausing to examine why public trust has collapsed, the WHO’s solution is to blame “misinformation,” push harder for catch-up campaigns like “The Big Catch-Up,” and prepare for the next round of rapid vaccine deployment during inevitable (or planned?) “future shocks.”

She explicitly calls for efforts to “debunk misinformation,” “build up trust,” and integrate surveillance, immunization, and emergency response systems. In plain English that means more censorship, more behavioral nudges, and tighter coordination between governments, Big Pharma, and international bodies to ensure compliance.

This comes after the highly controversial COVID-19 vaccine rollout — the most heavily promoted, mandated, and profitable pharmaceutical campaign in history — which left millions reporting injuries, excess deaths in highly vaccinated populations, and risks for myocarditis, neurological issues and fertility impacts that were dismissed or downplayed for years despite being legitimate concerns.

Keep reading

The Real Reason the FAA Authorized the COVID Shots Revealed in Court Documents

An experienced airline pilot claims he faced retaliation for opposing the COVID-19 shot, which he believes undermined personal liberties and aviation safety across the industry. He contends that these matters should be investigated as facts about the so-called vaccine and surrounding policies continue to emerge.

The Gateway Pundit spoke to Captain Bahig Saliba, a pilot who dedicated over 27 years to American Airlines. He opposed the airline’s policies and practices that were implemented during the declared pandemic. That led him to initiate pro se legal action against the airline and the Federal Aviation Administration (FAA) beginning in 2022, alleging retaliation and federal aviation law violations.

Saliba expressed concern regarding the infringement of personal liberties and aviation safety, noting that retaliation manifested in various forms, including a demand by American Airlines for a fitness for duty examination without any reason given, even when Saliba had an impeccable record.

Saliba emphasized that federal agencies must adhere to the Administrative Procedures Act (APA), which outlines the processes for rulemaking. “However, under the sovereign immunity umbrella,” he said, “agencies possess a wide range of discretion in rule and decision making.” With this discretion, he remarked, “agencies may not violate the law, but they often do.”

He argued that the FAA’s Federal Air Surgeon, Dr. Susan Northrup, wields the most discretion of all within the agency. She has the authority to medically certify pilots and air traffic controllers as well as to issue FAA medical certificates, he explained, adding, “that authority includes the prohibition or authorization of medication for use by holders of such certificates.”

“While the FAA medical certification is a civilian branch of government,” Saliba pointed out that “the U.S. military also benefits from the FAA expertise and authority in the field of aviation medicine.”

“The medical certification is not a simple visit to an FAA Aeromedical Examiner (AME) for a physical checkup,” the former airline pilot disclosed. Rather, it is a legal process detailed by Northrup herself in the video below.

Keep reading

Senate Investigation Finds FDA Officials Covered-Up 25 COVID Shot Safety Signals

A new Majority Staff Interim Report from Sen. Ron Johnson’s Permanent Subcommittee on Investigations was released today (April 29, 2026), titled Unmasked: How Biden Health Officials Purposely Turned a Blind Eye Toward COVID-19 Vaccine Safety Signals.

In early 2021 — just weeks after the COVID-19 vaccines rolled out under EUA — FDA senior medical officer Dr. Ana Szarfman (a key developer of the agency’s own data mining system) teamed up with Dr. William DuMouchel (the statistician who literally invented FDA’s “gold standard” EB data mining algorithm) to run an upgraded analysis on VAERS data.

Their new method (Regression-Adjusted Gamma Poisson Shrinker — RGPS) fixed a known flaw called “masking” — where signals for one COVID vaccine get drowned out by the sheer volume of reports from the others.

What they found was explosive:

  • 49 examples of extreme masking
  • ~25 new statistically significant safety signals that FDA’s standard MGPS method completely missed
  • Signals included: sudden cardiac death, acute myocardial infarction, pulmonary infarction, Bell’s palsy, non-site specific embolism/thrombosis, dementia, and “Death and sudden death” — for Pfizer, Moderna, and J&J shots

Dr. Szarfman repeatedly shared these findings with senior CBER officials (the very people in charge of vaccine safety), including Dr. Peter Marks, in March, April, May, and July 2021.

Their response?

  • Told her to “hold off” on creating and sending any more data mining reports
  • Called her work a “major distraction”
  • Worried it would “create erroneous conflicts that feed into anti-vaccination rhetoric”
  • Eventually ordered her to “cease and desist”

Later, FDA quietly locked down distribution of its own weekly data mining reports to CDC — right around the time FOIA requests and Sen. Johnson’s letters started coming in. One CDC official even admitted they may have asked FDA to stop sending them “because of the FOIAs.”

Even after Dr. Szarfman and DuMouchel published their findings in Drug Safety (2022) showing masking was eight times more likely with COVID vaccines, and Dr. Robert Califf replied “Thanks. These are good,” no changes were made to the methodology.

This is documented, internal FDA communication showing deliberate suppression of safety signals at the exact moment millions of Americans were being told the shots were “safe and effective.”

The cover-up continues to unravel. Accountability is urgently warranted.

Keep reading

mRNA Vaccines Linked to Catastrophic Ovarian Damage

A groundbreaking study reveals that mRNA vaccines trigger irreversible destruction of women’s primordial follicles — the finite ‘egg reserve’ that dictates fertility and menopause timing.

Karaman et al. (2024) found that rats injected with human-equivalent mRNA COVID-19 doses suffered:

  • more than 60% loss of primordial follicles (*p* < 0.001) — the non-renewable foundation of female fertility
  • plummeting Anti-Müllerian Hormone (AMH) — a key marker of ovarian reserve
  • a surge in follicle apoptosis (cell death) via elevated TGF-β1, VEGF, and caspase-3.

If this translates to humans, the implications are dire. Think early menopause, infertility, and a generational fertility crash.

There are human data reflecting this trend: Alvergne et al. (2022) reported disrupted menstrual cycles in 42% of vaccinated women, with some experiencing prolonged irregularities. However, more research is needed.

Keep reading

Researchers Push AI DESIGNED ‘Super Vaccine’

Cambridge scientists are hailing an AI-crafted “super-antigen” as a breakthrough that could ‘get ahead of pandemics’, blanket-protect against every COVID variant, and spare the world future lockdowns while saving millions of lives.

Yet the same public that lived through the last round of experimental shots is not buying the hype. Responses to the announcements have been blunt, laced with references to documented harms, AI’s well-known limitations, and fresh warnings from cancer specialists who watched stable patients relapse after previous boosters.

University of Cambridge researchers, led by Professor Jonathan Heeney, say they have produced the first antigen designed entirely by artificial intelligence and tested in humans.

The team fed AI systems genetic sequences from multiple coronaviruses collected through ongoing surveillance programs. The algorithm then assembled a “super-antigen” intended to train the immune system to recognize whole virus families rather than single strains that keep mutating.

Early human testing involved 39 volunteers and produced what researchers called modest immune responses but no major safety red flags in the initial readout. A larger study with roughly 200 participants is now running to measure stronger and more durable protection.

The same platform is being extended toward universal flu shots, H5N1 bird flu candidates, and vaccines against viral hemorrhagic fevers.

Keep reading

Study linking vaccines to SIDS deleted

If a scientific paper offers a counter-narrative conclusion, should it be deleted from the record?

Science publisher Elsevier says yes, if the topic is vaccines, because allowing doctors and parents to read it would pose a risk to public health.

This raises the question: Is censorship of science really the best way to ensure public health and safety?

The paper under scrutiny is a peer-reviewed analysis of three decades of vaccine adverse event reporting data which found that 75 percent of sudden infant deaths occurred within seven days of a vaccination, a statistically significant finding.

Author Neil Z. Miller reviewed the medical literature linking SIDS (sudden infant death syndrome) to vaccines and proposed several pathogenic mechanisms, concluding that, “While the findings in this paper are not proof of an association between infant vaccines and infant deaths, they are highly suggestive of a causal relationship.”

The main finding from the paper, titled ‘Vaccines and sudden infant death: An analysis of the VAERS database 1990–2019 and review of the medical literature,’ is represented in the below image, which was widely shared on social media since its publication in the journal Toxicology Reports, in June 2021.

Keep reading

Trump Signs Executive Order Backing HHS On Childhood Vaccine Reform — Will It Matter?

An executive order President Donald Trump signed late last Friday has reignited the national debate on the childhood immunization schedule.

The order directs public health agencies to align the schedule with a federal assessment published in January that calls for fewer recommended childhood vaccines and reflects the “scientific evidence and best practices from peer, developed countries while preserving access to vaccines currently available to Americans.”

The order states:

“The scientific assessment found that the United States currently recommends more childhood vaccines than any peer nation, including more than twice as many vaccine doses as some European nations, and identified a set of consensus vaccines that are consistently recommended in all peer countries.”

In a Substack post, Sayer Ji, chairman of the Global Wellness Forum and founder of GreenMedInfo, wrote, “After decades in which the schedule only ratcheted in one direction — more products, more doses, earlier and earlier — this is a top-down instruction to reconsider that trajectory.”

The executive order comes amid recent suggestions that the Trump administration has strategically pivoted away from vaccine policy in the lead-up to this year’s midterm elections.

But for Michael Kane, director of advocacy for Children’s Health Defense (CHD), the order “is a sign that examining the childhood vaccination schedule is a true priority.”

“The U.S. gives more vaccines to children before the age of 2 than nearly all other developed peer nations. In addition, we have the highest levels of chronic illness in children in the developed world. Lowering the number of recommended vaccines would allow us to see what role vaccination plays in the chronic illness epidemic we have in our nation,” Kane said.

Medical researcher Neil Z. Miller, who in 2023 co-authored a study finding a positive statistical correlation between infant mortality rates and the number of vaccine doses received by babies, agreed. “Many developed countries recommend a smaller set of vaccines universally while reserving others for specific risk groups. … The executive order establishes a clearer distinction between ‘core’ and ‘optional’ vaccines.”

The executive order also suggests guidance on how the federal government makes such vaccine recommendations and signals support for parental choice and the right to religious exemptions to vaccinations.

“This executive order is about far more than vaccines,” said Daniel O’Connor, founder and CEO of TrialSite News. “It’s about who gets to decide acceptable medical risk for America’s children.”

Keep reading

Lyme Vaccine Clinical Trials: History Repeating?

Why is there so much controversy surrounding Lyme disease? Why does it seem you can’t get an accurate Lyme disease test?

The State of Lyme

The incidence of Lyme disease is approaching half a million cases per year in the United States, according to a 2021 Centers for Disease Control & Prevention (CDC) report based on data from commercial insurance claims. Yet fewer than 40,000 cases are reported to the CDC in any given year, exposing a massive discrepancy between the actual prevalence of the disease and the few cases that meet the CDC’s surveillance reporting definition.

Despite its alarming incidence rate and often catastrophic effects on human health, there has been little advancement in diagnostic and therapeutic technologies for Lyme in the last 40 years. The CDC and Infectious Diseases Society of America (IDSA) continually support only the use of outdated serological techniques that are known to be inadequate, while simultaneously acknowledging that better tests are needed. The reasons for such double-speak and neglect are inextricably intertwined with the sordid history of Lyme disease vaccines.

Lyme vaccine development has continued for the last three decades despite evidence that the causative organism—the spirochetal bacteria Borrelia burgdorferi—evades immunity in multiple ways that may make it impossible for a vaccine to prevent infection. The most recent effort, a candidate known as VLA-15 from Pfizer and French biotech Valneva, is now in phase III trials. Last February it was revealed that due to alleged violations of good clinical practice, Pfizer had shut down all trial sites run by contractor Care Access, eliminating roughly half of the enrolled participants.

Pfizer’s record of “engaging in illegal and corrupt marketing practices, bribing physicians and suppressing adverse trial results” may alone warrant suspicion about their recent actions. But in the context of a Lyme vaccine, suspicion should be heightened. The last Lyme vaccine on the market, SmithKline Beecham’s LYMErix, was withdrawn in 2002 amid numerous injury claims, federal agency hearings, and class action lawsuits. Which begs the question, is history repeating?

Stepping back three decades

In June 1994, the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) devoted a lengthy meeting to the three companies that had Lyme vaccines in development. According to the official meeting transcript, the primary order of business was to answer the question, “Is the CDC case definition for Lyme disease appropriate for a pivotal efficacy trial?”

Why would this even be a question? The standard diagnostics at the time—mainly the ELISA, a serologic assay that measures antibodies produced against the bacteria—were known to produce a large proportion of false negatives. When the CDC discontinued routine testing of samples in its labs in 1988, it stated in a letter to the Oregon Public Health Laboratory that the sensitivity of the ELISA ranged from 13% to 27% in clinically recognized cases. Obviously, this would hamper any trial operator’s ability to assess possible Lyme infection and the vaccine’s overall effectiveness. If you can’t diagnose cases, how can you determine whether your vaccine works?

Keep reading

Secret Trial of Pfizer RSV Vaccine Killed Two Infants in the 1960s — Their Families Just Sued the U.S. Government

The families of two Black infants who died during a 1960s experimental RSV vaccine trial have filed a federal lawsuit against the U.S., alleging government researchers enrolled the babies in a dangerous medical experiment without their parents’ knowledge or consent, The New York Times reported.

The lawsuit, filed May 22 in the U.S. District Court for the District of Columbia, alleges the National Institutes of Health (NIH) and other researchers, in 1965 and 1966, subjected dozens of infants — most or all of them from low-income Black families — to testing of Pfizer’s Lot 100 experimental vaccine for respiratory syncytial virus, or RSV.

Two infants, Victor Marcellus King and Ross Otto Hambrick, later died after developing vaccine-associated enhanced respiratory disease (VAERD), a severe respiratory illness caused by the vaccine.

VAERD occurs when a vaccinated child who never had RSV is exposed to the virus and develops a more severe case of RSV than they would have if they hadn’t received the vaccine.

The suit was filed by Sharlette Hambrick and Darius King, acting as representatives of the estates of their deceased brothers. They allege federal researchers failed to obtain informed consent from the children’s parents, withheld critical information about prior vaccine failures, and continued the study despite mounting evidence that the vaccine was causing severe reactions in participants.

The complaint also alleges that the tissue samples from the babies who died were later used to develop the RSV vaccines and monoclonal antibody shots that have been approved in the last several years — providing a financial boon for drugmakers.

“Medical research in the United States has a long, troubled racial history,” the complaint states, comparing the alleged conduct to other notorious examples of unethical experimentation involving Black Americans, including the Tuskegee Syphilis Study and the exploitation of Henrietta Lacks.

The infants’ families were unaware the babies had been subjected to the experiment until a reporter from Undark magazine contacted them while investigating the story in 2023.

The reporter found the babies’ names in a doctor’s government-issued laboratory notebook and other paperwork from the clinical trial, the Times reported.

Parents not told infants were being enrolled in trial for experimental vaccine

Keep reading

Study Finds Pediatric Flu Shots are a COMPLETE FAILURE

A new peer-reviewed study evaluating the rollout of mass pediatric flu vaccination across an entire Spanish health region (~400,000 people) found NO statistically significant reduction in flu cases or hospitalizations after authorities expanded flu shots to children 6 months to 5 years old.

Researchers analyzed 6,804 primary care influenza diagnoses and 3,252 influenza-related hospitalizations between 2018 and 2025, comparing seasons before and after the pediatric flu shot program began in 2023.

Despite the rollout, the study’s more rigorous interrupted time series analysis found no measurable reduction in influenza diagnoses or hospital admissions among the target age groups (0–2 and 2–4 years).

In plain English: the flu shots did not meaningfully lower flu rates in young children. Kids under 5 were no less likely to show up at the doctor with the flu or end up hospitalized than expected after the rollout. In other words, the program failed to produce a measurable real-world benefit in the exact age group it was designed to protect.

Notably, researchers also looked across all age groups in the region to see whether vaccinating young children indirectly protected the broader community. Again, they found no statistically significant reduction in flu-related hospitalizations or meaningful population-level benefit following rollout.

The study ultimately concluded that routine pediatric influenza vaccination “has not been associated with a reduction in influenza cases in primary care or hospital settings.”

These results are not surprising given that the Cleveland Clinic recently found that flu shots were associated with a 27% higher risk of flu among healthcare workers during the 2024–2025 season.

Keep reading